✦ LIBER ✦

Development pathway for biodefense vaccines

✍ Scribed by Alan D.T. Barrett; David W.C. Beasley

Book ID: 116961881
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 331 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.07.094

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Smallpox vaccines for biodefense

✍ Richard B. Kennedy; Inna Ovsyannikova; Gregory A. Poland 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Viral vectors for use in the development

Viral vectors for use in the development of biodefense vaccines

✍ John S. Lee; Angela G. Hadjipanayis; Michael D. Parker 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Particulate delivery systems for biodefe

Particulate delivery systems for biodefense subunit vaccines

✍ Vincent W. Bramwell; Jim E. Eyles; H. Oya Alpar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Vaccines for Biodefense and Emerging and

Vaccines for Biodefense and Emerging and Neglected Diseases || American Trypanosomiasis

✍ Bhatia, Vandanajay 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 465 KB

The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing in

Policies for biodefense revisited: The p

Policies for biodefense revisited: The prioritized vaccination process for smallpox

✍ Moshe Kress 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 542 KB

Cost/success projections for US biodefen

Cost/success projections for US biodefense countermeasure development

✍ Matheny, Jason; Mair, Michael; Smith, Bradley 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB